Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH
This study has been completed.
Study NCT00588536   Information provided by Memorial Sloan-Kettering Cancer Center
First Received: December 26, 2007   Last Updated: June 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Langerhans Cell Histiocytosis
Additional conditions recognized in this trial
Histiocytosis
Histiocytosis, Langerhans-Cell
More general conditions related to this trial
Lung Diseases
Lung Diseases, Interstitial
Lymphatic Diseases
Respiratory Tract Diseases
Reticuloendotheliosis
Interventions listed in this trial
Methotrexate
6-Thioguanine
Leucovorin Calcium
Additional drug interventions recognized in this trial
6-Mercaptopurine
Leucovorin
Thioguanine
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services